BANGALORE, December 8, 2014 /PRNewswire/ --
Indegene (www.indegene.com ), a leading global provider of clinical, commercial, and marketing solutions to global life science, pharmaceutical, and healthcare organizations, announced the release of a proprietary MCM benchmark study identifying the Top 5 MCM Trends in China, Emerging Markets, and Japan to help pharmaceutical marketers make more data-driven MCM strategic and budgeting decisions.
The study includes views from 98 pharma marketers across Australia, China, India, Indonesia, Japan, Latin America, Malaysia, Middle East, and Turkey from top 30 life science organizations. The study uncovers the temperament of companies in each of these countries and their specific multichannel marketing adoption, preference, planning, and budgeting trends. "This study serves as an unbiased and fair guideline to all life science marketers in these countries to measure their current approach against a peer-based index. As the study reveals, marketers definitely need to relook at budget allocations, channel optimization and investing more in discovering the ideal MCM for their organization", summarized Mr. Manish Gupta - CEO, Indegene.
The study touches upon 5 key trends in the marketplace:
- The current digital landscape across markets
- Channel preference based on digital spend
- Organizational preference to channel adoption
- Preferred channel mix for value-added service
- Barriers to implementing MCM programs
To access the report, visit http://bit.ly/11O7T0v .
Indegene is a leading global provider of clinical, commercial, and marketing solutions to global life science and healthcare organizations. We partner with clients to create and deliver solutions for today and tomorrow by integrating technology, medical science, and communication expertise. Indegene improves provider and patient engagement; optimizes commercial, medical, and R&D costs; improves regulatory and safety compliance; enhances payer and provider quality; and accelerates revenues.
With offices in the United States, United Kingdom, China, India, and Australia, Indegene can partner globally with clients; leverage a global talent pool of clinicians, technologists, creative specialists, domain experts, business process specialists; deploy global infrastructure assets; and harness global healthcare knowledge to solve client challenges. To learn more visit us at www.indegene.com
For further information contact:
US and Europe
Ann Marie Craggan
Phone: +1 732.750.2901
Mobile: +91 9886332007
SOURCE Indegene Lifesystems Pvt Ltd